CTOs on the Move


 
Amylyx is a Cambridge-based pharmaceutical company dedicated to the development of therapeutics for the treatment of neurodegenerative disorders. Guided by our core values, we incorporate unconventional approaches through strong partnerships with industry leaders, scientists, doctors and organizations. We work collaboratively across everything we do to positively impact the lives of patients and their families.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.amylyx.com
  • 43 Thorndike Street
    Cambridge, MA USA 02141
  • Phone: 617.682.0917

Executives

Name Title Contact Details

Funding

Amylyx raised $14.7M on 01/28/2020

Similar Companies

Nanōmix

Nanōmix is the leader in mobile point-of-care diagnostics for use where time and accuracy is critical.

Weedmaps

Founded in 2008, Weedmaps is a leading technology and software infrastructure provider to the cannabis industry. Our suite of cloud-based software and data solutions includes point of sale, logistics and ordering solutions that enable customers to scale their businesses while complying with the complex and disparate regulations applicable to the cannabis industry. In addition, our platform provides consumers with information regarding cannabis products across web and mobile platforms, including listing local retailers and brands, facilitating product discovery and allowing consumers to educate themselves on cannabis and its history, uses and legal status. Headquartered in Irvine, California, Weedmaps employs more than 400 professionals around the world, with offices including Barcelona, Denver, and Toronto.

Collagen Matrix

Collagen Matrix advances the science of tissue repair and regeneration with collagen and mineral based medical devices that support the bodys natural ability to regenerate.

Oculus Innovative Sciences, Inc.

Oculus Innovative Sciences, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Articularis Healthcare Group

A physician led and owned organization committed to improving healthcare by supporting independent rheumatology practices across the nation and providing innovative technology to lower healthcare costs for providers and patients